RxDoctor Payments Data

Belur Patel, MD

Urology · Victoria, TXNPI 1891756680

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,638 of the $5,455 with a category attached, or 85.0%. 23 manufacturers reported payments, led by Procept Biorobotics Corporation at 27.0% of the total.

$5,455in general payments, 2019–2025

Across 82 payments — averaging $66.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$1K
  • Boston Scientific$435
  • Astellas Pharma US Inc$404
  • Calyxo, Inc.$362
  • Johnson & Johnson$312
  • Medtronic$302
  • plus $2K from 17 others
$34,321in research payments, 2019–2025

Across 15 payments — averaging $2288.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$34K

What the payments were for

  • Travel & lodging$55210%
  • Food & beverage$4,63885%
  • Education$2645%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,455 in reported general payments places this provider in the 60th percentile of 878 urology providers in Texas.

See all urology providers in Texas →

Medicare billing

Part B allowed, 2024
$162,057
Medicare patients
360
Services billed
1,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl286$2,134
Finasteride53$621
Trospium Chloride23$490
Oxybutynin Chloride21$276
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim82$195
Levofloxacin93$188
Tramadol Hcl75$170
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$130
NitrofurantoinNitrofurantoin Macrocrystal11$100

Paid to pharmacies, not to this prescriber.

Other urology in Victoria

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →